Last reviewed · How we verify

NCT03926572: PROPULS

Acute Decompensation of Pulmonary Hypertension

Completed NA Last updated 26 October 2024
What this trial tests

NA trial testing A biobank will be created from blood samples taken at admission, days 3 and days 7 in Hypertension, Pulmonary in 145 participants. Completed in 16 December 2022.

Timeline
19 September 2019
Primary endpoint
12 December 2022
16 December 2022

Quick facts

Lead sponsorAssistance Publique - Hôpitaux de Paris
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment145
Start date19 September 2019
Primary completion12 December 2022
Estimated completion16 December 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with Hypertension, Pulmonary or Biomarkers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to analyze the survival of a cohort of patients admitted for acute decompensation of pulmonary arterial hypertension or postembolic pulmonary hypertension and to establish the prognostic value of biomarkers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypertension, Pulmonary

Currently open trials in the same condition.

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03926572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing